Cargando…
Clinical predictors for a complicated course of disease in an inception cohort of patients with ulcerative colitis: results from the prospective, observational EPICOL study
PURPOSE: The clinical course of ulcerative colitis (UC) is highly heterogeneous, with 20 to 30% of patients experiencing chronic disease activity requiring immunosuppressive or biologic therapies. The aim of this study was to identify predictors for a complicated disease course in an inception cohor...
Autores principales: | Schmidt, Carsten, Bokemeyer, Bernd, Lügering, Andreas, Bettenworth, Dominik, Teich, Niels, Fischer, Imma, Hammer, Leonie, Kolterer, Stefanie, Rath, Stefan, Stallmach, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803753/ https://www.ncbi.nlm.nih.gov/pubmed/35084534 http://dx.doi.org/10.1007/s00384-022-04098-7 |
Ejemplares similares
-
Medical Therapy of Active Ulcerative Colitis
por: Bürger, Martin, et al.
Publicado: (2015) -
Self-assessment of treatment targets in patients with inflammatory bowel disease using a survey
por: Reuken, Philipp A., et al.
Publicado: (2020) -
Detection and characterization of murine colitis and carcinogenesis by molecularly targeted contrast-enhanced ultrasound
por: Brückner, Markus, et al.
Publicado: (2017) -
COVID-19 und chronisch-entzündliche Darmerkrankungen
por: Teich, Niels, et al.
Publicado: (2023) -
Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis
por: Feagan, Brian G, et al.
Publicado: (2019)